AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zensita M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Zuventus Healthcare Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Zensita M 50mg/500mg Tablet

Diabetica Duo 50mg/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like vision loss and kidney disease, potentially lowering heart attack and stroke risk. Diabetica Duo may be used independently or with other diabetes treatments, and is most effective when coupled with a balanced diet and regular physical activity. Dosage is personalized based on your health, blood sugar readings, and existing medications. Consuming it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under medical guidance. Adherence to your prescribed diet and exercise plan is crucial for optimal diabetes control. Common side effects include nausea, vomiting, diarrhea, stomach discomfort, headache, and sore throat. Low blood sugar (hypoglycemia) is a potential side effect, especially when used with insulin or sulfonylureas; learn to identify and manage this. This medication isn't suitable for all patients. Inform your doctor about any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption before starting. Pregnant or breastfeeding individuals should seek medical advice. Interactions with other medications are possible; disclose all medications to your doctor to ensure safety. Alcohol should be minimized due to its hypoglycemic effect. Your doctor will monitor your kidney function and blood sugar levels throughout treatment.

Primary Ingredients of Zensita M 50mg/500mg Tablet

The provided text is "undefined," so there is nothing to rephrase.

Uses of Zensita M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Zensita M 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Zensita M 50mg/500mg tablets should be administered with a meal.

Common Side effects of Zensita M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Zensita M 50mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Zensita M 50mg/500mg tablets should be taken with meals.

How Zensita M 50mg/500mg Tablet works:

Zensita M, a 50mg/500mg tablet, combines sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action promotes more effective blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Zensita M 50mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Zensita M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Zensita M 50mg/500mg tablets may present a safety risk. Preliminary human evidence indicates potential transfer to breast milk with the possibility of infant harm.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Zensita M 50mg/500mg Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The medication is contraindicated for those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Zensita M 50mg/500mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Zensita M 50mg/500mg Tablet :

Should you forget a Zensita M 50mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Zensita M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Zensita M 50mg/500mg Tablet

Zensita M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Zensita M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Zensita M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with allergies to Zensita M 50mg/500mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Zensita M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Zensita M 50mg/500mg Tablets. This is due to a buildup of lactic acid in the blood and is rare, but avoided in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Zensita M and seek immediate medical attention.
Zensita M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Zensita M 50mg/500mg Tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may result in vitamin B12 deficiency.
Zensita M 50mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Zensita M 50mg/500mg tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Zensita M 50mg/500mg tablets. This occurs due to excessive lactic acid buildup in the blood and is rare, but more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Zensita M and seek immediate medical attention.
Prolonged use of Zensita M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes including balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Zensita M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Zensita M 50mg/500mg Tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Zensita M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Zensita M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA—Metformin-associated lactic acidosis), is a potential side effect of Zensita M 50mg/500mg tablets. This occurs due to elevated blood lactic acid levels. Because it's rare, metformin is avoided in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Zensita M and seek immediate medical attention.
Prolonged use of Zensita M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Zensita M 50mg/500mg Tabl...
169